Clinical Outcomes and Prognostic Factors of Patients With Early Malignant Melanoma in One Latin American Country : Results of the Epidemiological Registry of Malignant Melanoma in Colombia Study
To describe the population with early malignant melanoma, we performed a cohort study on the basis of the Epidemiological Registry of Malignant Melanoma in Colombia-Asociacion Colombiana de Hematologia y Oncologia. From January 2011 until December 2021, 759 patients were included; the average age was 66 years, 57% were women, acral lentiginous histology was found in 27.8% of patients, and the median follow-up was 36.5 months. The prognostic factors for overall survival in our population are Eastern Cooperative Oncology Group 3-4 (hazard ratio [HR], 13.8), stage III (HR, 5.07), received radiotherapy (HR, 3.38), ulceration on histology (HR, 2.68), chronic sun exposure (HR, 2.3), low income (HR, 2.04), previous local surgery (HR, 0.27), and have received adjuvant treatment (HR, 0.41).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
JCO global oncology - 9(2023) vom: 01. Mai, Seite e2200377 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ospina Serrano, Aylen Vanessa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 24.05.2023 Date Revised 13.12.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1200/GO.22.00377 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357190920 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357190920 | ||
| 003 | DE-627 | ||
| 005 | 20231227131256.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/GO.22.00377 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM357190920 | ||
| 035 | |a (NLM)37216624 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ospina Serrano, Aylen Vanessa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical Outcomes and Prognostic Factors of Patients With Early Malignant Melanoma in One Latin American Country |b Results of the Epidemiological Registry of Malignant Melanoma in Colombia Study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.05.2023 | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a To describe the population with early malignant melanoma, we performed a cohort study on the basis of the Epidemiological Registry of Malignant Melanoma in Colombia-Asociacion Colombiana de Hematologia y Oncologia. From January 2011 until December 2021, 759 patients were included; the average age was 66 years, 57% were women, acral lentiginous histology was found in 27.8% of patients, and the median follow-up was 36.5 months. The prognostic factors for overall survival in our population are Eastern Cooperative Oncology Group 3-4 (hazard ratio [HR], 13.8), stage III (HR, 5.07), received radiotherapy (HR, 3.38), ulceration on histology (HR, 2.68), chronic sun exposure (HR, 2.3), low income (HR, 2.04), previous local surgery (HR, 0.27), and have received adjuvant treatment (HR, 0.41) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Contreras, Fernando |e verfasserin |4 aut | |
| 700 | 1 | |a Triana, Iván |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez-Vanegas, Guillermo |e verfasserin |4 aut | |
| 700 | 1 | |a Ortíz, Juan David |e verfasserin |4 aut | |
| 700 | 1 | |a Ramos, Pedro |e verfasserin |4 aut | |
| 700 | 1 | |a Vargas, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Arango, Natalia |e verfasserin |4 aut | |
| 700 | 1 | |a Idrobo, Henry |e verfasserin |4 aut | |
| 700 | 1 | |a Munévar, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Yepes, Andrés |e verfasserin |4 aut | |
| 700 | 1 | |a Mantilla, William |e verfasserin |4 aut | |
| 700 | 1 | |a Jiménez, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Rivas, Giovanna |e verfasserin |4 aut | |
| 700 | 1 | |a Lema, Mauricio |e verfasserin |4 aut | |
| 700 | 1 | |a Alcalá, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Gómez, Diego |e verfasserin |4 aut | |
| 700 | 1 | |a Chinchia, Matilde |e verfasserin |4 aut | |
| 700 | 1 | |a Barrero, Angela |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JCO global oncology |d 2020 |g 9(2023) vom: 01. Mai, Seite e2200377 |w (DE-627)NLM30617877X |x 2687-8941 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2023 |g day:01 |g month:05 |g pages:e2200377 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1200/GO.22.00377 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2023 |b 01 |c 05 |h e2200377 | ||